Company news

Immunovia AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Immunovia announces final terms of rights issue

October 28, 2026

Immunovia Publishes Interim Report for April-June 2026

August 6, 2026

Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage

June 15, 2026

Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure

June 10, 2026

Immunovia Publishes Interim Report for January-March 2026

May 7, 2026

Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance

May 5, 2026

Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants 45758458 v6)

May 4, 2026

Proposal for resolution on (A) option program for management and key persons; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for management and key persons and B directed issue of warrants and approval of transfer of warrants)

April 14, 2026

Proposal for resolution on authorization of the board to resolve on new issue of shares (Proposal for resolution on authorization regarding issues)

April 14, 2026

Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants)

April 14, 2026

Annual Report (Immunovia AB publ Annual Report 2025)

April 14, 2026

Statement from nomination committee (Statement from nomination committee 2026)

April 14, 2026

Notice to annual general meeting 2026 (notice of annual general meeting in immunovia ab publ)

April 14, 2026

Immunovia publishes the Annual Report for 2025

April 10, 2026

Remuneration Report (Remuneration Report 2026 Updated)

April 9, 2026

Immunovia Publishes Full Year Report for 2025

February 24, 2026

Invitation to presentation of Immunovia's Q4 2025 report

February 23, 2026

Immunovia receives state regulatory approval for PancreaSure in California and initiates commercial rollout

January 19, 2026

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 13 decks. Every deck is listed under its year.